<DOC>
	<DOCNO>NCT02868190</DOCNO>
	<brief_summary>This study objective evaluate intraocular pressure ( IOP ) lower effect two trabecular micro-bypass stent ( iStent inject ) eye subject primary open-angle glaucoma one topical hypotensive medication</brief_summary>
	<brief_title>Two Second-Generation Trabecular Micro-bypass Stents Treat Glaucoma Subjects One Hypotensive Medication</brief_title>
	<detailed_description>The study design follow : Prospective Subjects medicate IOP &gt; 18 mmHg ≤ 30 mmHg Subjects one topical ocular hypotensive medication prior stent implantation Implantation two iStent device ( IOP &lt; 6 mmHg , point postoperative follow-up , medication prescribe discontinue ) IOP measure two ( 2 ) observer minimize bias ; observer 1 look slit lamp turn dial reading mask , observer 2 document IOP Diurnal IOP measurements Follow-up 60 month postoperative ( could 61 month subject need undergo terminal washout ) Descriptive statistic tabulate Medical therapy consider necessary subject 's welfare implement time study investigator 's discretion</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>INCLUSION CRITERIA : Screening Exam Phakic patient pseudophakic patient posterior chamber intraocular lens ( PCIOLs ) . Primary openangle glaucoma ( include pigmentary pseudoexfoliative ) . Cuptodisc ratio ≤ 0.9 . Visual field defect , nerve abnormality characteristic glaucoma . One topical hypotensive medication time screen exam . Intraocular pressure ( IOP ) &gt; 18 mmHg ≤ 30 mmHg ( medicate ) screen exam . Study eye BCVA 20/100 well . Normal angle anatomy determine gonioscopy . Absence peripheral anterior synechia ( PAS ) , rubeosis angle abnormality could impair proper placement stent . Baseline Exam Subject complete appropriate medication washout . Mean IOP &gt; 22 mmHg ≤ 38 mmHg antiglaucoma medication washout period . EXCLUSION CRITERIA : Screening Exam Aphakic patient pseudophakic patient anterior chamber IOLs ( ACIOLs ) . Prior stent implantation ( study eye ) . Traumatic , uveitic , neovascular , angleclosure glaucoma ; glaucoma associate vascular disorder . Functionally significant visual field loss , include severe nerve fiber bundle defect Bjerrum scotoma . Prior incisional glaucoma surgery . Prior SLT within 90 day prior screen . Prior ALT . Iridectomy laser iridotomy . Ineligibility ocular hypotensive medication washout period determine investigator : visual field status would place risk washout period , unmedicated IOP washout period would expect exceed upper limit ≥ 38 mmHg . Any active corneal inflammation edema ( e.g. , keratitis , keratoconjunctivitis , keratouveitis ) . Clinically significant corneal dystrophy ( e.g. , bullous keratopathy , Fuch 's dystrophy ) ; guttata . Corneal surgery ( prior anticipate ) type ( include LASIK , LASEK , PRK , etc . ) may interfere IOP measurement reliability . Corneal opacities disorder would inhibit visualization nasal angle . Congenital traumatic cataract . Retinal optic nerve disorder , either degenerative evolutive , associate exist glaucoma condition . Elevated episcleral venous pressure associate : active thyroid orbitopathy , cavernous sinus fistula , SturgeWeber syndrome , orbital tumor , orbital congestive disease . Clinically significant sequela trauma ( e.g. , chemical burn , blunt trauma , etc. ) . Chronic ocular inflammatory disease presence active ocular inflammation ( e.g. , uveitis , iritis , iridocyclitis , retinitis ) . Pregnant nursing woman . Baseline Exam Subject complete medication washout . Mean IOP &lt; 22 mmHg &gt; 38 mmHg antiglaucoma medication washout . Subject 3mmHg IOP increase screen mean diurnal IOP .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>